FDA Drugs (New Approvals & NDA)Original article
FDA Inter-governmental Working Meeting on Drug Compounding, Nov. 1-2, 2022
RegulatoryNeutral
AI Analysis
Summary
The FDA and state regulators held their 11th annual inter-governmental working meeting on November 1-2, 2022, with nearly 300 federal and state participants to discuss strengthening oversight of drug compounders.
Importance:2/10
Sentiment:
0.00
FDADrug CompoundingRegulatory OversightInter-governmental Meeting
Read the original article
Published by FDA Drugs (New Approvals & NDA) on June 3, 2026 7:50 PM